Under‐representation of elderly in clinical trials: An analysis of the initial approval documents in the Food and Drug Administration database

AIMS: To evaluate the availability of pharmacokinetic, safety and efficacy analyses specifically targeted at elderly, prior to the authorization of drugs. METHODS: A cross‐sectional, structured review of publicly available initial approval documents of Food and Drug Administration‐approved drugs was...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiter, Rikje, Burggraaf, Jacobus, Rissmann, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422639/
https://www.ncbi.nlm.nih.gov/pubmed/30681181
http://dx.doi.org/10.1111/bcp.13876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422639/
https://www.ncbi.nlm.nih.gov/pubmed/30681181
http://dx.doi.org/10.1111/bcp.13876

Ejemplares similares